Device Trial Radar · NCT00069615
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children
Last checked: Nov 20, 2026Latest source record: Sep 5, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Feb 2003
Primary completion
Not stated
Study completion Jun 2003
Sponsor
- Lead sponsor
- Jaeb Center for Health ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Sep 30, 2003
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Who can join
- All sexes, from 7 years, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Devices such as the GlucoWatch G2 Biographer (GW2B), which constantly measure blood sugar levels, may improve the treatment of Type 1 diabetes mellitus in children. This study evaluated the GW2B when used by children in their homes.
Conditions
- Diabetes Mellitus, Insulin-Dependent
Interventions
GlucoWatch® G2™ Biographer (GW2B)Device
Continuous Glucose Monitoring System™ (CGMS)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Feasibility of using the GlucoWatch G2 Biographer
- Feasibility of collecting data from home computers
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Division of Pediatric Endocrinology and Diabetes, Stanford University
Stanford, California
Barbara Davis Center for Childhood Diabetes, University of Colorado
Denver, Colorado
Department of Pediatrics, Yale University School of Medicine
New Haven, Connecticut
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.